NUVA Fundamental Analysis - NORATIS AG

Fundamental Rating

Taking everything into account, NUVA scores 2 out of 10 in our fundamental rating. NUVA was compared to 75 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NUVA have multiple concerns. NUVA is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NUVA has reported negative net income.

NUVA had a positive operating cash flow in the past year.

In multiple years NUVA reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: NUVA reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of NUVA (-6.76%) is worse than 74.67% of its industry peers.

Looking at the Return On Equity, with a value of -46.91%, NUVA is doing worse than 81.33% of the companies in the same industry.

Looking at the Return On Invested Capital, with a value of 0.60%, NUVA is doing worse than 60.00% of the companies in the same industry.

NUVA had an Average Return On Invested Capital over the past 3 years of 1.90%. This is in line with the industry average of 3.75%.

		Industry Rank	Sector Rank
ROA	-6.76%
ROE	-46.91%
ROIC	0.6%

ROA(3y)-2.47%

ROA(5y)-0.91%

ROE(3y)-16.73%

ROE(5y)-6.94%

ROIC(3y)1.9%

ROIC(5y)2.12%

1.3 Margins

NUVA has a Operating Margin (4.96%) which is in line with its industry peers.

In the last couple of years the Operating Margin of NUVA has declined.

Looking at the Gross Margin, with a value of 20.00%, NUVA is doing worse than 60.00% of the companies in the same industry.

NUVA's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	4.96%
PM (TTM)	N/A
GM	20%

OM growth 3Y-20.54%

OM growth 5Y-12.31%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.05%

GM growth 5Y-6.76%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUVA is destroying value.

The number of shares outstanding for NUVA has been increased compared to 1 year ago.

The number of shares outstanding for NUVA has been increased compared to 5 years ago.

NUVA has a worse debt/assets ratio than last year.

2.2 Solvency

NUVA has an Altman-Z score of 1.25. This is a bad value and indicates that NUVA is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.25, NUVA is in the better half of the industry, outperforming 62.67% of the companies in the same industry.

NUVA has a debt to FCF ratio of 10.14. This is a negative value and a sign of low solvency as NUVA would need 10.14 years to pay back of all of its debts.

NUVA's Debt to FCF ratio of 10.14 is fine compared to the rest of the industry. NUVA outperforms 73.33% of its industry peers.

A Debt/Equity ratio of 5.49 is on the high side and indicates that NUVA has dependencies on debt financing.

Looking at the Debt to Equity ratio, with a value of 5.49, NUVA is doing worse than 88.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	5.49
Debt/FCF	10.14
Altman-Z	1.25

ROIC/WACC0.16

WACC3.63%

2.3 Liquidity

A Current Ratio of 14.73 indicates that NUVA has no problem at all paying its short term obligations.

With an excellent Current ratio value of 14.73, NUVA belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.

A Quick Ratio of 0.52 indicates that NUVA may have some problems paying its short term obligations.

NUVA has a Quick ratio of 0.52. This is in the lower half of the industry: NUVA underperforms 64.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	14.73
Quick Ratio	0.52

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NUVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.72%.

The Revenue has grown by 10.60% in the past year. This is quite good.

The Revenue has been decreasing by -2.61% on average over the past years.

EPS 1Y (TTM)-71.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%31.39%

Revenue 1Y (TTM)10.6%

Revenue growth 3Y-3.3%

Revenue growth 5Y-2.61%

Sales Q2Q%71.55%

3.2 Future

NUVA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.63% yearly.

The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.

EPS Next Y79%

EPS Next 2Y41.68%

EPS Next 3Y26.7%

EPS Next 5Y15.63%

Revenue Next Year-24.2%

Revenue Next 2Y8.52%

Revenue Next 3Y10.31%

Revenue Next 5Y9.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NUVA. In the last year negative earnings were reported.

Also next year NUVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

NUVA's Enterprise Value to EBITDA ratio is in line with the industry average.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of NUVA indicates a rather cheap valuation: NUVA is cheaper than 98.67% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	0.34
EV/EBITDA	93.3

4.3 Compensation for Growth

NUVA's earnings are expected to grow with 26.70% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.68%

EPS Next 3Y26.7%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NUVA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NORATIS AG

FRA:NUVA (10/10/2025, 7:00:00 PM)

0.865

-0.05 (-5.46%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)10-02 2025-10-02

Earnings (Next)N/A N/A

Inst Owners0.22%

Inst Owner ChangeN/A

Ins Owners0.7%

Ins Owner ChangeN/A

Market Cap11.74M

Analysts42.22

Price Target1.79 (106.94%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)63.2%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-35.22%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-60.53%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.18
P/FCF	0.34
P/OCF	0.34
P/B	0.2
P/tB	0.2
EV/EBITDA	93.3

EPS(TTM)-3.76

EYN/A

EPS(NY)-0.89

Fwd EYN/A

FCF(TTM)2.56

FCFY295.47%

OCF(TTM)2.56

OCFY295.48%

SpS4.9

BVpS4.41

TBVpS4.41

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.76%
ROE	-46.91%
ROCE	0.85%
ROIC	0.6%
ROICexc	0.61%
ROICexgc	0.61%
OM	4.96%
PM (TTM)	N/A
GM	20%
FCFM	52.11%

ROA(3y)-2.47%

ROA(5y)-0.91%

ROE(3y)-16.73%

ROE(5y)-6.94%

ROIC(3y)1.9%

ROIC(5y)2.12%

ROICexc(3y)1.95%

ROICexc(5y)2.2%

ROICexgc(3y)1.95%

ROICexgc(5y)2.2%

ROCE(3y)2.69%

ROCE(5y)3.01%

ROICexcg growth 3Y-26.63%

ROICexcg growth 5Y-23.14%

ROICexc growth 3Y-26.63%

ROICexc growth 5Y-23.14%

OM growth 3Y-20.54%

OM growth 5Y-12.31%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.05%

GM growth 5Y-6.76%

F-Score4

Asset Turnover0.16

Health

		Industry Rank	Sector Rank
Debt/Equity	5.49
Debt/FCF	10.14
Debt/EBITDA	86.08
Cap/Depr	0.39%
Cap/Sales	0%
Interest Coverage	0.19
Cash Conversion	909.63%
Profit Quality	N/A
Current Ratio	14.73
Quick Ratio	0.52
Altman-Z	1.25

F-Score4

WACC3.63%

ROIC/WACC0.16

Cap/Depr(3y)14.01%

Cap/Depr(5y)16.5%

Cap/Sales(3y)0.08%

Cap/Sales(5y)0.13%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-71.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%31.39%

EPS Next Y79%

EPS Next 2Y41.68%

EPS Next 3Y26.7%

EPS Next 5Y15.63%

Revenue 1Y (TTM)10.6%

Revenue growth 3Y-3.3%

Revenue growth 5Y-2.61%

Sales Q2Q%71.55%

Revenue Next Year-24.2%

Revenue Next 2Y8.52%

Revenue Next 3Y10.31%

Revenue Next 5Y9.4%

EBIT growth 1Y-66.19%

EBIT growth 3Y-23.16%

EBIT growth 5Y-14.59%

EBIT Next Year124.3%

EBIT Next 3Y38.46%

EBIT Next 5Y23.46%

FCF growth 1Y51.49%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y51.37%

OCF growth 3YN/A

OCF growth 5YN/A

NORATIS AG (NUVA.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens